SecBot SecBot
6-K ·Filed Sep 16, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 3/10
Horizondays Processed2mo ago SEC0001654954-26-008396
Actionable Insight • Neutral

This is a routine debt refinancing with no equity impact. Monitor the final tender results and the new note's coupon to assess any interest expense savings, but no near-term catalyst for SNN common stock.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$27.80
T+0 close · Sep 16, 2026 · via day close
Latest settled
+0.22%
T+20 · $27.86 · next T+60 in 23d
Vs SPY
−2.96%
α at T+20
Latest observation
+12.75%
T+41 · FF3 residual α
  1. T+0 · Sep 16 $27.80entry
  2. T+1 · 2mo ago −0.07%α −1.21% · $27.78
  3. T+5 · 8w ago −3.53%α −6.09% · $26.82
  4. T+20 · 5w ago +0.22%α −2.96% · $27.86
  5. T+43 · todayOpen
  6. T+60 · in 23d Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Smith & Nephew priced its cash tender offer to purchase up to $250 million of its 2.032% Senior Notes due 2030 (out of $900 million outstanding) at $878.90 per $1,000 principal, with settlement expected September 18, 2026. This completes the debt refinancing announced on September 8, 2026, where the company issued new 10-year senior notes to fund the tender. The transaction is a routine liability management exercise that reduces near-term maturities without changing the company's overall leverage profile or equity value, and has no material impact on SNN common stock fundamentals.

Key Facts

  • Smith & Nephew priced a cash tender offer for up to $250 million of its 2.032% Senior Notes due 2030.
  • The tender offer consideration was set at $878.90 per $1,000 principal amount.
  • The tender offer expired at 5:00 p.m. New York City time on September 15, 2026.
  • Settlement is expected on September 18, 2026.
  • The financing condition for the tender offer has been satisfied.
  • This tender offer is part of a debt refinancing that was announced on September 8, 2026, alongside the issuance of new 10-year senior unsecured notes due 2036.
  • The company generated annual sales of $6.2 billion in 2025.

Financial Impact

Up to $250 million of debt repurchased at a discount (approximately 12.1% below par), funded by a new 10-year note issuance. Net leverage unchanged.

debtinterest expense

Risk Factors

  • If the tender is oversubscribed, proration may leave some bondholders with unexpected holdings.
  • The new 10-year notes could carry a higher coupon than the retired 2.032% notes, potentially increasing interest expense.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
46% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 8 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (SNN), Batch item 10001654954-26-008396
Document: 0001654954-26-008396-index-headers.html0001654954-26-008396
Document: 0001654954-26-008396-index.html0001654954-26-008396
Document: 0001654954-26-008396.txt0001654954-26-008396
6-K Filing (SNN), Batch item 50001654954-26-008396
Document: 0001654954-26-008396-index-headers.html0001654954-26-008396
Document: 0001654954-26-008396-index.html0001654954-26-008396
Document: 0001654954-26-008396.txt0001654954-26-008396

Track record

42 reports on SNN

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +8.02% at T+20 after the Jun 30, 2026 report. 8 of 9 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 1/10 Entry $31.00 Now $30.97 −0.10% settles Nov 19
  2. Nov 4, 202612d ago 6-K Bearish 6/10 No price data
  3. Nov 4, 202612d ago 6-K Bearish 6/10 Entry $32.46 to $31.04 Now $30.97 +4.59% ▲ +4.37% +3.46% vs SPY
  4. Nov 2, 202614d ago 6-K Neutral 4/10 Entry $30.24 to $31.05 Now $30.97 +2.41% ▲ +2.68% +2.60% vs SPY
  5. Oct 22, 202625d ago 6-K Neutral 2/10 Entry $30.88 to $30.22 Now $30.97 +0.29% ▼ −2.14% −2.84% vs SPY
  6. Oct 8, 20265w ago 6-K Neutral 2/10 Entry $26.96 to $29.09 Now $30.97 +14.87% ▲ +7.90% +8.18% vs SPY
  7. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  8. Oct 1, 20266w ago 6-K Neutral 2/10 Entry $26.58 to $26.96 Now $30.97 +16.52% ▲ +1.43% +0.13% vs SPY
  9. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
  10. Sep 23, 20267w ago Press Release Neutral 3/10 Entry $26.82 to $26.96 Now $30.97 +15.47% ▲ +0.52% +1.20% vs SPY
Showing 10 of 42

US Market Status

Market Closed · Opens Wed (11h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 16, 2026